Cells study helping to crack the code to Alzheimer's disease

November 25, 2019

A study led by researchers at Monash University has opened up new hope for diagnosing and treating Alzheimer's disease.

Alzheimer's disease is the most common form of dementia in older people and, as there are no effective treatments, is one of the leading contributors to the global disease burden.

Various genes have been implicated in the changes that happen in the brains of Alzheimer's patients. What is not known is how the activity of the genes - called gene expression - affects the many different cells of the brain.

The study, led by Monash University's Professor Jose Polo, from the Monash Biomedicine Discovery Institute and the Australian Regenerative Medicine Institute, focused on how individual cell types in the brain contribute to Alzheimer's disease.

Through a series of complex tests, they looked at patterns in gene expression in specific cells and how changes in specific cell subpopulations are associated with Alzheimer's.

The researchers were excited to make a number of key discoveries into understanding Alzheimer's disease that require further study.

This included the role of disease gene networks, genes working together, in the human brain, pathways to genetic susceptibility, subcellular changes in areas of the brain, and the role of myelination in Alzheimer's disease pathogenesis.

The study was co-led with researchers from Duke-National University of Singapore and in collaboration with the University of Melbourne, Florey Institute, the University of Western Australia and the Harry Perkins Institute of Medical Research. This is an excellent outcome from the Monash International Network of Excellence program, that is designed to bring together new international teams working towards the solution of big problems.

In a paper published in Nature Neuroscience on Tuesday, November 26, the researchers said: "although our study contributes significantly to our understanding of the transcriptional changes underpinning changes in brain cells in Alzheimer's disease, examining larger patient cohorts in the future will enable assessment of the effects and relative contribution of underlying genetic factors to the described cellular and transcriptomic changes in disease.

"We anticipate that our resource will stimulate and allow further discoveries in many different areas, as exemplified by our work."

Professor Polo said the findings are an exciting step in eventually diagnosing and treating Alzheimer's disease.

"Alzheimer's disease is an increasingly prevalent cause of dementia in ageing societies like Australia and Singapore. Despite billions of funds poured in, an effective drug has yet to be discovered," the lead researchers said.

"In order to make advancements, there is a need to focus on other cell types in the brain aside from neurons - the main cell type in the brain.

A key researcher in the study, Dr Alexandra Grubman, from Monash University's Australian Regenerative Medicine Institute and a NHMRC-ARC Dementia Fellow, is excited at the new therapeutic possibilities the study has opened.

"Perhaps the answer to treating Alzheimer's lies in understanding how these non-neuronal cells are affected during disease," she said.

This multinational team will now conduct further research on genes that can potentially be treated with medical drugs.
-end-
Contact:
Media, Monash University
T: +61 3 9903 4840
E: media@monash.edu

Monash University

Related Science Articles from Brightsurf:

75 science societies urge the education department to base Title IX sexual harassment regulations on evidence and science
The American Educational Research Association (AERA) and the American Association for the Advancement of Science (AAAS) today led 75 scientific societies in submitting comments on the US Department of Education's proposed changes to Title IX regulations.

Science/Science Careers' survey ranks top biotech, biopharma, and pharma employers
The Science and Science Careers' 2018 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Science in the palm of your hand: How citizen science transforms passive learners
Citizen science projects can engage even children who previously were not interested in science.

Applied science may yield more translational research publications than basic science
While translational research can happen at any stage of the research process, a recent investigation of behavioral and social science research awards granted by the NIH between 2008 and 2014 revealed that applied science yielded a higher volume of translational research publications than basic science, according to a study published May 9, 2018 in the open-access journal PLOS ONE by Xueying Han from the Science and Technology Policy Institute, USA, and colleagues.

Prominent academics, including Salk's Thomas Albright, call for more science in forensic science
Six scientists who recently served on the National Commission on Forensic Science are calling on the scientific community at large to advocate for increased research and financial support of forensic science as well as the introduction of empirical testing requirements to ensure the validity of outcomes.

World Science Forum 2017 Jordan issues Science for Peace Declaration
On behalf of the coordinating organizations responsible for delivering the World Science Forum Jordan, the concluding Science for Peace Declaration issued at the Dead Sea represents a global call for action to science and society to build a future that promises greater equality, security and opportunity for all, and in which science plays an increasingly prominent role as an enabler of fair and sustainable development.

PETA science group promotes animal-free science at society of toxicology conference
The PETA International Science Consortium Ltd. is presenting two posters on animal-free methods for testing inhalation toxicity at the 56th annual Society of Toxicology (SOT) meeting March 12 to 16, 2017, in Baltimore, Maryland.

Citizen Science in the Digital Age: Rhetoric, Science and Public Engagement
James Wynn's timely investigation highlights scientific studies grounded in publicly gathered data and probes the rhetoric these studies employ.

Science/Science Careers' survey ranks top biotech, pharma, and biopharma employers
The Science and Science Careers' 2016 annual Top Employers Survey polled employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries to determine the 20 best employers in these industries as well as their driving characteristics.

Three natural science professors win TJ Park Science Fellowship
Professor Jung-Min Kee (Department of Chemistry, UNIST), Professor Kyudong Choi (Department of Mathematical Sciences, UNIST), and Professor Kwanpyo Kim (Department of Physics, UNIST) are the recipients of the Cheong-Am (TJ Park) Science Fellowship of the year 2016.

Read More: Science News and Science Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.